Corporate News 26-Jun-23
Ajanta Pharma's Dahej unit clears USFDA audit
Ajanta Pharma announced that the company's formulation facility at Dahej was inspected by US FDA from 19 June 2023 to 23 June 2023. At the end of inspection, no Form 483 was issued to the company.
Previous News
Ajanta Pharma fixes record date for buyback of shares
( Market Beat - Reports 10-Mar-23 13:20 )
Ajanta Pharma consolidated net profit rises 24.71% in the September 2023 quarter
( Results - Announcements 31-Oct-23 14:10 )
Ajanta Pharma
( Results - Analysis 01-Feb-23 17:14 )
Board of Ajanta Pharma approves buyback of shares for Rs 315 cr
( Corporate News - 10-Mar-23 11:33 )
Ajanta Pharma consolidated net profit rises 8.58% in the December 2021 quarter
( Results - Announcements 31-Jan-22 16:24 )
Ajanta Pharma board OKs Rs 315-cr share buyback
( Hot Pursuit - 10-Mar-23 11:54 )
Ajanta Pharma to hold board meeting
( Corporate News - 19-Oct-23 17:17 )
Volumes jump at Ajanta Pharma Ltd counter
( Hot Pursuit - 22-Dec-22 11:00 )
Ajanta Pharma gains on buyback proposal
( Hot Pursuit - 24-Dec-21 09:23 )
Ajanta Pharma standalone net profit declines 47.30% in the March 2019 quarter
( Results - Announcements 02-May-19 09:44 )
Ajanta Pharma consolidated net profit rises 60.76% in the December 2019 quarter
( Results - Announcements 06-Feb-20 11:46 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
